J Clin Oncol 15 (4): 1318-32, 1997.[PUBMED Abstract] Hensley ML, Schuchter LM, Lindley C, et al.: American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
J Clin Oncol 17 (10): 3333-55, 1999.[PUBMED Abstract] Marty M, Espi√© M, Llombart A, et al.: Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy.
Ann Oncol 17 (4): 614-22, 2006.[PUBMED Abstract] Hortobagyi GN, Frye D, Buzdar AU, et al.: Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.